206 related articles for article (PubMed ID: 6869833)
1. Development of a serum-free medium for growth of NS-1 mouse myeloma cells and its application to the isolation of NS-1 hybridomas.
Kawamoto T; Sato JD; Le A; McClure DB; Sato GH
Anal Biochem; 1983 Apr; 130(2):445-53. PubMed ID: 6869833
[TBL] [Abstract][Full Text] [Related]
2. Serum-free medium for the growth of NS-1 mouse myeloma cells and the isolation of NS-1 hybridomas.
Kawamoto T; Sato JD; McClure DB; Sato GH
Methods Enzymol; 1986; 121():266-77. PubMed ID: 3724465
[No Abstract] [Full Text] [Related]
3. Enhanced formation of mouse hybridomas without hat treatment in a serum-free medium.
Yabe N; Matsuya Y; Yamane I; Takada M
In Vitro Cell Dev Biol; 1986 Jul; 22(7):363-8. PubMed ID: 3733634
[TBL] [Abstract][Full Text] [Related]
4. Production of a highly specific monoclonal antibody progesterone.
White A; Anderson DC; Daly JR
J Clin Endocrinol Metab; 1982 Jan; 54(1):205-7. PubMed ID: 7054217
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol requirement of NS-1 mouse myeloma cells for growth in serum-free medium.
Sato JD; Kawamoto T; McClure DB; Sato GH
Mol Biol Med; 1984 Apr; 2(2):121-34. PubMed ID: 6533417
[TBL] [Abstract][Full Text] [Related]
6. An alternative method for the isolation of NS-1 hybridomas using cholesterol auxotrophy of NS-1 mouse myeloma cells.
Myoken Y; Okamoto T; Osaki T; Yabumoto M; Sato GH; Takada K; Sato JD
In Vitro Cell Dev Biol; 1989 May; 25(5):477-80. PubMed ID: 2732203
[TBL] [Abstract][Full Text] [Related]
7. Development of mouse hybridomas by fusion of myeloma cells with lymphocytes derived from spleen, lymph node, and bone marrow.
Başalp A; Yücel F
Hybrid Hybridomics; 2003 Oct; 22(5):329-31. PubMed ID: 14678651
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of limiting dilution in cloning mouse myeloma-spleen hybridomas by human low density lipoproteins.
Mao SJ; France DS
J Immunol Methods; 1984 Dec; 75(2):309-16. PubMed ID: 6520402
[TBL] [Abstract][Full Text] [Related]
9. Increased yield of antibody-producing murine spleen cell hybridomas from fusions cultured in medium supplemented with mouse serum.
Persson MA; Lerner RA
J Immunol Methods; 1990 Feb; 127(1):39-42. PubMed ID: 2319141
[TBL] [Abstract][Full Text] [Related]
10. Improved fusion technique. II. Stability and purity of hybrid clones.
Westerwoudt RJ; Naipal AM; Harrisson CM
J Immunol Methods; 1984 Mar; 68(1-2):89-101. PubMed ID: 6538588
[TBL] [Abstract][Full Text] [Related]
11. Optimization of growth and secretion of human monoclonal antibodies by hybridomas cultured in serum-free media.
Lang AB; Schuerch U; Cryz SJ
Hybridoma; 1991 Jun; 10(3):401-9. PubMed ID: 1916851
[TBL] [Abstract][Full Text] [Related]
12. Colcemid treatment of myeloma prior to cell fusion increases the yield of hybridomas between myeloma and splenocyte.
Miyahara M; Nakamura H; Hamaguchi Y
Biochem Biophys Res Commun; 1984 Nov; 124(3):903-8. PubMed ID: 6508785
[TBL] [Abstract][Full Text] [Related]
13. Hybridoma cell lines secreting monoclonal antibodies against foot-and-mouth disease virus. 1. Cell culturing requirements.
McCullough KC; Butcher RN; Parkinson D
J Biol Stand; 1983 Jul; 11(3):171-81. PubMed ID: 6309848
[TBL] [Abstract][Full Text] [Related]
14. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
Posner MR; Elboim H; Santos D
Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
[TBL] [Abstract][Full Text] [Related]
15. Serum-free medium for hybridoma and parental myeloma cell cultivation: a novel composition of growth-supporting substances.
Kovár J; Franĕk F
Immunol Lett; 1984; 7(6):339-45. PubMed ID: 6724641
[TBL] [Abstract][Full Text] [Related]
16. Making hybridomas.
Burns R
Methods Mol Biol; 2005; 295():41-54. PubMed ID: 15596887
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent reduction of apoptosis in nutrient-limited cultures of NS/0 myeloma cells transfected with the E1B-19K adenoviral gene.
Mercille S; Jolicoeur P; Gervais C; Paquette D; Mosser DD; Massie B
Biotechnol Bioeng; 1999 Jun; 63(5):516-28. PubMed ID: 10397808
[TBL] [Abstract][Full Text] [Related]
18. Cell biology of human IgM-producing hybridomas derived from a fusion of human spleen lymphocytes with mouse myeloma cells.
Jahn S; Grunow R; Kiessig ST; Bogacheva GT; Arsenjeva EL; Hlinak A; Rocklin OV; von Baehr R
Hybridoma; 1987 Dec; 6(6):679-87. PubMed ID: 3436627
[TBL] [Abstract][Full Text] [Related]
19. Modifications of hybridoma technology which improve the yield of monoclonal antibody producing cells.
Orlik O; Altaner C
J Immunol Methods; 1988 Nov; 115(1):55-9. PubMed ID: 2848072
[TBL] [Abstract][Full Text] [Related]
20. Purification of monoclonal antibodies with light-chain heterogeneity produced by mouse hybridomas raised with NS-1 myelomas: application of hydrophobic interaction high-performance liquid chromatography.
Abe N; Inouye K
J Biochem Biophys Methods; 1993 Oct; 27(3):215-27. PubMed ID: 7505010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
